2015
DOI: 10.1111/ddg.12534
|View full text |Cite
|
Sign up to set email alerts
|

Spindle cell squamous cell carcinoma arising from verrucous hyperplasia during BRAF inhibitor therapy for melanoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
4
0
2

Year Published

2015
2015
2023
2023

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 0 publications
0
4
0
2
Order By: Relevance
“…However, pre-existing skin lesions are not a prerequisite [6]. During targeted therapy of malignant melanoma with BRAF inhibitors verrucous hyperplasia is frequently observed that may develop into well differentiated squamous cell carcinomas of the kerato-acanthoma type [7]. A causative relation of the verrucous carcinoma in our patient and the preceding treatment with ixekizumab is unlikely.…”
Section: Your Diagnosis? … Diagnosis: Verrucous Carcinomamentioning
confidence: 70%
“…However, pre-existing skin lesions are not a prerequisite [6]. During targeted therapy of malignant melanoma with BRAF inhibitors verrucous hyperplasia is frequently observed that may develop into well differentiated squamous cell carcinomas of the kerato-acanthoma type [7]. A causative relation of the verrucous carcinoma in our patient and the preceding treatment with ixekizumab is unlikely.…”
Section: Your Diagnosis? … Diagnosis: Verrucous Carcinomamentioning
confidence: 70%
“…It shows a predilection for sun-damaged skin of the head and neck area of elderly males in the 7 th and 8 th decade. Cases of development from other skin neoplasia (for example, keratoacanthoma-like SCC and verrucous tumor HPV-induced) in patients under BRAF inhibitors therapy, 6 have been recently reported.…”
Section: Discussionmentioning
confidence: 99%
“…Umgekehrt sind vorbestehende chronische Hautläsionen aber keine Bedingung für das Entstehen eines verrukösen Karzinoms [6]. Verruköse Hyperplasien, aus denen hochdifferenzierte Plattenepithelkarzinome vom Keratoakanthom-Typ entstehen können, werden neuerdings unter der zielgerichteten Therapie des malignen Melanoms mit BRAF-Inhibitoren beobachtet [7].…”
Section: Anamnese Und Klinische Befundeunclassified